Advanced visualization and artificial intelligence (AI) software developer Coreline Soft has received clearance from the U.S. Food and Drug Administration (FDA) for its Aview LCS lung cancer screening computer-aided detection software.
Aview LCS helps clinicians identify and characterize lung nodules on low-dose CT (LDCT), cutting imaging interpretation time by 70%, increasing sensitivity by 34%, and decreasing false positives by 42%, according to Coreline Soft.
